Cambridge-based health technology company developing AI-driven blood screening technology to enable earlier and more accessible detection of cardiovascular disease and other complex conditions. The company combines RNA sequencing with proprietary artificial intelligence analysis to identify disease-related biomarkers from a simple blood sample. Its liquid biopsy technology is designed to support low-cost, remote, and potentially routine screening, helping healthcare professionals identify disease risk earlier and monitor patients over time. MultiplAI Health is based at The Bradfield Centre on Cambridge Science Park and is focused on making advanced preventative healthcare more accessible.